Published in Mol Med Rep on September 05, 2014
The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med (2013) 3.96
The many faces and functions of β-catenin. EMBO J (2012) 3.85
Role of Wnt/β-catenin signaling in liver metabolism and cancer. Int J Biochem Cell Biol (2009) 1.55
Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib. Clin Cancer Res (2012) 1.44
Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer. Br J Cancer (2007) 1.33
Wnt/β-catenin signalling: from plasma membrane to nucleus. Biochem J (2013) 1.31
SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway. Gynecol Oncol (2008) 1.28
The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma. Oncogene (2010) 1.23
β-catenin as a potential key target for tumor suppression. Int J Cancer (2011) 1.23
SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma. Hepatology (2012) 1.10
Oral cancer: Current role of radiotherapy and chemotherapy. Med Oral Patol Oral Cir Bucal (2013) 1.10
Epigenetic regulation of DACT2, a key component of the Wnt signalling pathway in human lung cancer. J Pathol (2013) 1.09
Secreted Frizzled-related protein-2 (sFRP2) augments canonical Wnt3a-induced signaling. Biochem Biophys Res Commun (2010) 1.07
Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active β-catenin. Oncogene (2010) 1.04
DNA methylation as an epigenetic biomarker in colorectal cancer. Oncol Lett (2013) 1.03
Genistein attenuates WNT signaling by up-regulating sFRP2 in a human colon cancer cell line. Exp Biol Med (Maywood) (2011) 1.00
Hypermethylation and aberrant expression of Wnt-antagonist family genes in gastric cardia adenocarcinoma. Neoplasma (2011) 0.97
Decreased expression and aberrant hypermethylation of the SFRP genes in human gastric cancer. Hepatogastroenterology (2011) 0.97
Tumor-suppressor Gene Promoter Hypermethylation in Saliva of Head and Neck Cancer Patients. Transl Oncol (2012) 0.96
A Wnt-er migration: the confusing role of β-catenin in melanoma metastasis. Sci Signal (2013) 0.91
Decreased expression of the p63 related proteins beta-catenin, E-cadherin and EGFR in oral lichen planus. Oral Oncol (2007) 0.89
Molecular changes in invasive front of oral cancer. J Oral Maxillofac Pathol (2013) 0.88
Role of CSN5/JAB1 in Wnt/β-catenin activation in colorectal cancer cells. FEBS Lett (2012) 0.87
Epigenetic dysregulation of secreted Frizzled-related proteins in multiple myeloma. Cancer Lett (2009) 0.87
DNA methylation in oral squamous cell carcinoma: molecular mechanisms and clinical implications. Oral Dis (2011) 0.86
Promoter hypermethylation in primary squamous cell carcinoma of the oral cavity and oropharynx: a study of a Brazilian cohort. Mol Biol Rep (2012) 0.85
Altered epigenetic regulation of homeobox genes in human oral squamous cell carcinoma cells. Exp Cell Res (2013) 0.85
The role of secreted frizzled-related protein 2 expression in prostate cancer. Histopathology (2011) 0.83
Clinicopathologic significance of β-catenin and matrix metalloproteinase-2 expression in non-small cell lung cancer. Med Oncol (2013) 0.81
Down-regulation of tripartite-motif containing 22 expression in breast cancer is associated with a lack of p53-mediated induction. Biochem Biophys Res Commun (2013) 0.80
Unexpected alteration of β-catenin and c-KIT expression by 5-FU and docetaxel in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro. Anticancer Res (2013) 0.78
SL-01, an oral derivative of gemcitabine, inhibited human breast cancer growth through induction of apoptosis. Biochem Biophys Res Commun (2013) 0.77